Understanding the effect of Hao-Fountain syndrome-causing mutations on neuronal development
Full Description
ABSTRACT
Hao-Fountain syndrome is a newly identified rare pediatric neurodevelopmental disorder caused by deletions
and mutations of the USP7 gene. The molecular mechanisms and pathophysiology of the disease remain poorly
understood, preventing the development of potential treatments for Hao-Fountain patients. USP7 is a
deubiquitinating enzyme implicated in the maintenance of protein homeostasis, stem cell identity, self-renewal,
and control of dendritic branching in primary neurons. A model system has not yet been created but is
indispensable for understanding the disease and for the evaluation of potential personalized therapies for Hao-
Fountain Syndrome. In this proposal, we will create the first human-based cellular model of Hao-Fountain to test
the effect of disease-linked mutations on the enzymatic function of USP7 (Aim 1), and on neuron differentiation
potential and morphology (Aim 2). The patient-derived induced pluripotent stem cells will be differentiated into
cortical neurons to create the Hao-Fountain model system that will be shared with the greater community to
accelerate the understanding of this newly discovered and devastating disease.
Grant Number: 1R21NS135343-01A1
NIH Institute/Center: NIH
Principal Investigator: Irina Bezsonova
Sign up free to get the apply link, save to pipeline, and set email alerts.
Sign up free →Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click